You’ll find our best evidence on using intravenous immunoglobulin (IVIG) – on label or off label – to treat different medical conditions.

We’ve selected the following materials to get you started:

• Off-Label Use of Intravenous Immunoglobulin (IVIG) (In Brief: A Summary of the Evidence, November 2018)
• Off-Label Use of Intravenous Immunoglobulin for Solid Organ Transplant Rejection: A Review of Clinical Effectiveness (Summary With Critical Appraisal, April 2018)
• Off-Label Use of Intravenous Immunoglobulin for Dermatological Conditions: A Review of Clinical Effectiveness (Summary With Critical Appraisal, April 2018)
• Off-Label Use of Intravenous Immunoglobulin for Autoimmune or Inflammatory Conditions: A Review of Clinical Effectiveness (Summary With Critical Appraisal, April 2018)
• Off-Label Use of Intravenous Immunoglobulin for Hematological Conditions: A Review of Clinical Effectiveness (Summary With Critical Appraisal, March 2018)
• Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions: A Review of Clinical Effectiveness (Summary With Critical Appraisal, March 2018)